Abstract
The great plasticity of Schwann cells (SCs), the myelinating glia of the peripheral nervous system (PNS), is a critical feature in the context of peripheral nerve regeneration following traumatic injuries and peripheral neuropathies. After a nerve damage, SCs are rapidly activated by injury-induced signals and respond by entering the repair program. During the repair program, SCs undergo dynamic cell reprogramming and morphogenic changes aimed at promoting nerve regeneration and functional recovery. SCs convert into a repair phenotype, activate negative regulators of myelination and demyelinate the damaged nerve. Moreover, they express many genes typical of their immature state as well as numerous de-novo genes. These genes modulate and drive the regeneration process by promoting neuronal survival, damaged axon disintegration, myelin clearance, axonal regrowth and guidance to their former target, and by finally remyelinating the regenerated axon. Many signaling pathways, transcriptional regulators and epigenetic mechanisms regulate these events. In this review, we discuss the main steps of the repair program with a particular focus on the molecular mechanisms that regulate SC plasticity following peripheral nerve injury.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Schwann cells and peripheral nerve injuries
Axonal repair in the central nervous system (CNS) is extremely limited after injury. In contrast, the PNS exhibits a high regenerative capacity. This ability is to a large extent due to the remarkable plasticity of SCs. During development, myelinating SCs form a one-to-one relationship with large caliber axons and wrap them in a myelin sheath, while non-myelinating SCs, also called Remak SCs, surround multiple small caliber axons without producing myelin. Upon axon injury, myelinating and non-myelinating SCs undergo extensive reprogramming that promotes and guides axonal repair. SCs lose contact with and demyelinate the distal stump axon and convert into a repair phenotype. This phenotypic transformation involves the downregulation of several pro-myelinating genes. Repair SCs are characterized by a specific profile which enables the regeneration process. SC reprogramming involves the upregulation of several genes and the activation of multiple transcriptional mechanisms [1,2,3]. Among the main players, c-Jun, mitogen-activated protein kinase (MAPK) pathways, Sonic Hedgehog (Shh) and chromatin modifications control and regulate the repair program. In the injured site, repair SCs participate in the disintegration and removal of damaged axons during the process of Wallerian degeneration and assist myelin debris clearance to create a regrowth favorable environment. Myelin debris clearance is achieved by the digestion of both intrinsic and extrinsic myelin fragments by means of myelinophagy and phagocytosis and the recruitment and activation of invading macrophages [4, 5]. Afterwards, SCs secrete trophic factors to support survival of damaged neurons and promote axon regrowth [1, 6]. Repair and Remak SCs also extend long parallel processes and align in tracts called bands of Büngner to guide the regrowing axon back to innervate its former target [3, 7]. Finally, SCs proliferate, upregulate pro-myelinating genes, re-differentiate into myelinating SCs and remyelinate the regenerated axon. An overview of the repair program is illustrated in Fig. 1. This repair machinery requires a dynamic and orchestrated regulation of SC plasticity and reprogramming following axon injury. Although the underlying molecular mechanisms remain still partially understood, several research groups have significantly contributed to our current understanding of how the key steps involved in the PNS repair program are controlled, which we will discuss in the next chapters of this review.
Repair program in the PNS. Illustration of the main steps of the repair program orchestrated by SCs after peripheral nerve injury. Each step shows a schematic representation of a single neuron (blue) interacting with SCs (light yellow) within an adult peripheral nerve undergoing a traumatic lesion. In step 4, macrophages (green cells) help SCs to clear axon and myelin debris
Nerve injury and methods in regeneration research
The severity of peripheral nerve injuries is classified depending on whether demyelination occurs and on the extent of axonal and connective tissue damage [8]. The mildest form called neurapraxia is characterized by local demyelination without axon or connective tissue lesion. Axonal lesion in addition to demyelination but with preserved connective tissue is a more severe injury called axonotmesis, while in the most severe form of injury, which is called neurotmesis, axons and the connective tissue are fully transected [9]. A more detailed classification with five different severity degrees followed Seddon’s classification [10]. SC plasticity and regeneration potential have been extensively studied both in vivo and in vitro. In vivo studies involved the use of wild type and transgenic animals. Among the methods used to study regeneration, nerve transection and crush injury models are the most commonly employed. The crush injury model offers some particular advantages. It is typically performed through an acute traumatic compression of the nerve and it interrupts all the axons but preserves the SC basal lamina. This allows for an optimal regeneration and to investigate the SC regeneration potential. Rats and mice are often used in research for sciatic nerve lesions to model human PNS lesions [11, 12]. In vitro studies mainly involve the use of cell lines, primary or organotypic ex vivo cell cultures. These models present great ethical advantages and they allow to investigate signalling pathways specifically induced by different molecules and drugs on SCs and/or neurons [13, 14]. Although they are unable to fully predict what happens at the whole organ level, primary SC/neuron cocultures have been useful PNS models to investigate the molecular mechanisms involved in axonal regrowth fostered by SCs and remyelination. Moreover, microfluidic devices, which allow the compartmentalization of neuronal cell bodies, axons and myelinating cells, have demonstrated to be useful in in vitro research [15, 16].
Schwann cell reprogramming
SC reprogramming following peripheral nerve injury can be divided in two main partially overlap** processes: SC demyelination and conversion or transdifferentiation into repair SCs [5, 17]. The demyelination process is characterized by the repression of pro-myelinating genes such as Early growth response 2 (Erg2 or Krox20) and of myelin genes including Myelin basic protein (Mbp), Myelin protein zero (Mpz or P0), Peripheral myelin protein 22 (Pmp22) and Myelin associated glycoprotein (Mag). Moreover, genes typically expressed during development including genes coding for L1, neural cell adhesion molecule (NCAM), p75 neurotrophin receptor (p75NTR) and glial fibrillary acidic protein (GFAP), are re-expressed or upregulated [17, 18]. However, repair SCs differ from immature SCs during development by several aspects. Indeed, they are characterized by de-novo expression of genes that include Olig1 and Shh and by the upregulation of many proteins involved in the regeneration process. Among those, (1) c-Jun, the main driver of the SC-dependent repair program, glial cell-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT3), artemin, nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and VEGF receptor 1 support the survival of injured neurons and promote the regrowth of proximal axons [1, 16, 18,19,20]; (2) leukemia inhibitory factor (LIF), interleukin-1α (IL-1α) and -1β (IL-1β), tumor necrosis factor-α (TNF-α) and monocyte chemotactic protein 1 (MCP-1) initiate the immune response, promote macrophage invasion and activation, blood vessel formation and myelin breakdown [1, 21,22,23,24]; (3) c-Jun, SRY-box 2 (Sox2) and neuregulin 1 (NRG1) are involved in SC morphological changes and axoglial interactions, in the formation of a nerve bridge in case of nerve transection and of the regeneration tracks along which axons regrow; (4) zinc finger E-box-binding homeobox 2 (Zeb2), nuclear factor-kappa B (NF-kB) and histone deacetylases 1 and 2 (HDAC1/2) are involved in the remyelination of the regenerated axon [25,26,27,28,29]. A summary of the main factors involved in the regeneration process is illustrated in Fig. 2, while a more detailed description of the main factors and signaling pathways with the most recent findings is discussed below.
Summary of the main factors regulated after peripheral nerve injury. Overview of factors downregulated during demyelination (blue area), factors expressed during the repair program (green area), and factors involved in re-myelination post-injury (red area). Uphill areas indicate a high expression, whereas downhill areas indicate a low expression. Regulation of factors is illustrated throughout the different steps of the regeneration process
Epigenetic regulation and other chromatin-remodeling enzyme functions
The complexity of the repair program requires a strict orchestration of gene expression and signalling pathways. Among the many levels of regulation, epigenetic regulation and chromatin-remodeling enzymes have been related to many aspects of SC development, maintenance and plasticity after peripheral nerve injury [2]. In SCs of uninjured nerves, Polycomb repressive complex 2 (PCR2) adds trimethyl marks to histone H3 lysine 27 (H3K27me3) on promoter regions of several genes to repress the expression of these genes and PRC2 inactivation results in the induction of genes that are normally upregulated following peripheral nerve injury [30]. Upon injury, H3K27 demethylation together with H3K4 methylation at promoter regions and H3K27 acetylation at enhancer regions promote the activation of injury-induced genes expressed during the repair program such as Shh and Gdnf [2, 30,31,32]. Recently, much research has focused on the functions of HDACs. By deacetylating and controlling the activity of non-histone targets including transcription factors, these enzymes have been shown to play key roles in the regulation of SC behavior following peripheral nerve lesion. HDAC1 and HDAC2, which belong to class 1 HDACs, have crucial functions in SC development including myelination and in PNS maintenance during adulthood [1, 24, 33]. Moreover, they are strongly upregulated following axonal injury [29]. Recent studies revealed that by interacting with Sox10, HDAC2 recruits the H3K9 demethylases KDM3A and JMJD2C to form a complex that de-represses and activates Oct6 and Krox20 genes during the repair program. In turn, Oct6, which is upregulated too early after lesion, negatively regulates c-Jun expression and thereby delays the conversion of SCs into repair SCs. Genetic inactivation of HDAC1/2 prevents Oct6 and Krox20 upregulation after lesion, which results in faster axonal regrowth but impairs the remyelination process. Interestingly, short-term treatment early after lesion with Mocetinostat, a pharmacological inhibitor of HDAC1/2, accelerates the regeneration process without impairing the remyelination process [29]. These findings are of particular interest for the development of potential treatments to improve peripheral nerve regeneration when lesions have led to large gaps between axons and their targets. Indeed, functional recovery of peripheral nerves after lesion is critically dependent on the speed of axon reconnection to their former target [34]. HDAC3, another class 1 HDAC, has been shown instead to limit myelination [119]. Notch inhibits myelination and its expression is downregulated at the beginning of the myelination process [121]. Moreover, Notch antagonistic activity to Krox20 classifies it as a negative regulator of myelination [17]. In adult nerves, Notch dysregulation results in demyelination, which suggests an involvement in the signaling pathway that induces myelin breakdown in vivo. Indeed, inhibition of Notch signaling in adult mice decelerates myelin breakdown that occurs after a nerve lesion [120]. In addition, Wang et al. [122] showed how the addition of Jagged1, a Notch activator, in rat injured nerves enhances functional nerve repair, suggesting that Notch stimulation in SCs could represent an interesting therapeutic strategy promoting nerve repair.
Conclusion
The PNS displays a remarkable ability to regenerate following injury. This process involves the coordinated action of multiple cell types and signaling pathways. Early after injury, damaged axons respond by generating a distress signal detected by SCs, which initiate the repair program. SCs respond by undergoing dynamic reprogramming and assuming an alternative differentiation state suited to meet the specific requirements arising from the injured condition. Although peripheral nerves display an impressive regenerative capacity as compared to the CNS, recovery for patients suffering from traumatic injuries and others peripheral neuropathies is often incomplete. This is mainly a result of the slow regeneration rate, which can reach approximately 1 mm per day, depending on the lesion site, and on the absence of a long-lasting repair-supportive environment. Moreover, the PNS repair ability decreases over time. SCs slowly lose their plasticity in an age-dependent way and the PNS environment becomes unsupportive to regeneration [45, 123]. Therefore, a greater understanding of the mechanisms driving SC plasticity is of utmost interest. Extensive research has been devoted to highlight the molecular mechanisms involved in SC reprogramming to provide mechanistic insights and novel therapeutic strategies to treat peripheral nerve injuries as well as to identify possible correlations with CNS mechanisms and strategies to improve CNS regeneration. Recent work demonstrates the involvement of morphogenetic transformations, epigenetic mechanisms and highlight many transcription factors and signaling pathways critical in this process. However, their induction and the temporal/quantitative activation as well as their mutual interactions have not been completely elucidated and future work should focus on learning how to manipulate repair cells, how to increase their repair-supportive functions, and how to extend their actions to meet the long periods required for axonal regeneration in clinical environment.
References
Jessen KR, Arthur-Farraj P (2019) Repair Schwann cell update: adaptive reprogramming, EMT, and stemness in regenerating nerves. Glia 67:421–437. https://doi.org/10.1002/glia.23532
Jacob C (2017) Chromatin-remodeling enzymes in control of Schwann cell development, maintenance and plasticity. Curr Opin Neurobiol 47:24–30. https://doi.org/10.1016/j.conb.2017.08.007
Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, Banerjee A, Woodhoo A, Jenkins B, Rahman M, Turmaine M, Wicher GK, Mitter R, Greensmith L, Behrens A, Raivich G, Mirsky R, Jessen KR (2012) c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75:633–647. https://doi.org/10.1016/j.neuron.2012.06.021
Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, Palomo-Irigoyen M, Varela-Rey M, Mirsky R, Woodhoo A, Jessen KR (2015) Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. Glia 63:E127–E128. https://doi.org/10.1083/jcb.201503019
Jessen KR, Mirsky R (2016) The repair Schwann cell and its function in regenerating nerves. J Physiol Lond 594:3521–3531. https://doi.org/10.1113/Jp270874
Madduri S, Gander B (2010) Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst 15:93–103. https://doi.org/10.1111/j.1529-8027.2010.00257.x
Jessen KR, Mirsky R, Lloyd AC (2015) Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol 7:a020487. https://doi.org/10.1101/cshperspect.a020487
Seddon HJ (1943) Peripheral nerve injuries. Glasgow Med J 139:61–75
Menorca RMG, Fussell TS, Elfar JC (2013) Nerve physiology mechanisms of injury and recovery. Hand Clin 29:317–330. https://doi.org/10.1016/j.hcl.2013.04.002
Sunderland S (1951) A classification of peripheral nerve injuries producing loss of function. Brain 74:491–516. https://doi.org/10.1093/brain/74.4.491
Bauder AR, Ferguson TA (2012) Reproducible mouse sciatic nerve crush and subsequent assessment of regeneration by whole mount muscle analysis. J Vis Exp 60:3606. https://doi.org/10.3791/3606
Luis AL, Rodrigues JM, Geuna S, Amado S, Shirosaki Y, Lee JM, Fregnan F, Lopes MA, Veloso AP, Ferreira AJ, Santos JD, Armada-Da-silva PA, Varejao AS, Mauricio AC (2008) Use of PLGA 90:10 scaffolds enriched with in vitro-differentiated neural cells for repairing rat sciatic nerve defects. Tissue Eng Part A 14:979–993. https://doi.org/10.1089/ten.tea.2007.0273
Shin YK, Jang SY, Park JY, Park SY, Lee HJ, Suh DJ, Park HT (2013) The Neuregulin-Rac-Mkk7 pathway regulates antagonistic c-Jun/Krox20 expression in Schwann cell dedifferentiation. Glia 6:892–904. https://doi.org/10.1002/glia.22482
Schmid D, Zeis T, Schaeren-Wiemers N (2014) Transcriptional regulation induced by cAMP elevation in mouse Schwann cells. ASN Neuro 6:137–157. https://doi.org/10.1042/AN20130031
Vaquie A, Sauvain A, Jacob C (2018) Modeling PNS and CNS myelination using microfluidic chambers. Methods Mol Biol 1791:157–168. https://doi.org/10.1007/978-1-4939-7862-5_12
Vaquie A, Sauvain A, Duman M, Nocera G, Egger B, Meyenhofer F, Falquet L, Bartesaghi L, Chrast R, Lamy CM, Bang S, Lee SR, Jeon NL, Ruff S, Jacob C (2019) Injured axons instruct Schwann cells to build constricting actin spheres to accelerate axonal disintegration. Cell Rep 27:3152–3166.e7. https://doi.org/10.1016/j.celrep.2019.05.060
Jessen KR, Mirsky R (2008) Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56:1552–1565. https://doi.org/10.1002/glia.20761
Chen ZL, Yu WM, Strickland S (2007) Peripheral regeneration. Annu Rev Neurosci 30:209–233. https://doi.org/10.1146/annurev.neuro.30.051606.094337
Fontana X, Hristova M, Da Costa C, Patodia S, Thei L, Makwana M, Spencer-Dene B, Latouche M, Mirsky R, Jessen KR, Klein R, Raivich G, Behrens A (2012) c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J Cell Biol 198:127–141. https://doi.org/10.1083/jcb.201205025
Scheib J, Hoke A (2013) Advances in peripheral nerve regeneration. Nat Rev Neurol 9:668–676. https://doi.org/10.1038/nrneurol.2013.227
Martini R, Fischer S, Lopez-Vales R, David S (2008) Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56:1566–1577. https://doi.org/10.1002/glia.20766
Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S (2011) Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes. J Neuroinflammation 8:24. https://doi.org/10.1186/1742-2094-8-24
Bauer S, Kerr BJ, Patterson PH (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8:221–232. https://doi.org/10.1038/nrn2054
Cafferty WBJ, Gardiner NJ, Gavazzi I, Powell J, McMahon SB, Heath JK, Munson J, Cohen J, Thompson SWN (2001) Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci 21:7161–7170. https://doi.org/10.1523/Jneurosci.21-18-07161.2001
Gomez-Sanchez JA, Pilch KS, van der Lans M, Fazal SV, Benito C, Wagstaff LJ, Mirsky R, Jessen KR (2017) After nerve injury, lineage tracing shows that myelin and remak schwann cells elongate extensively and branch to form repair Schwann cells, which shorten radically on remyelination. J Neurosci 37:9086–9099. https://doi.org/10.1523/Jneurosci.1453-17.2017
Parrinello S, Napoli I, Ribeiro S, Digby PW, Fedorova M, Parkinson DB, Doddrell RDS, Nakayama M, Adams RH, Lloyd AC (2010) EphB signaling directs peripheral nerve regeneration through Sox2-dependent schwann cell sorting. Cell 143:145–155. https://doi.org/10.1016/j.cell.2010.08.039
Fricker FR, Bennett DL (2011) The role of neuregulin-1 in the response to nerve injury. Future Neurol 6:809–822. https://doi.org/10.2217/fnl.11.45
Quintes S, Brinkmann BG, Ebert M, Frob F, Kungl T, Arlt FA, Tarabykin V, Huylebroeck D, Meijer D, Suter U, Wegner M, Sereda MW, Nave KA (2016) Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nat Neurosci 19:1050–1059. https://doi.org/10.1038/nn.4321
Brugger V, Duman M, Bochud M, Munger E, Heller M, Ruff S, Jacob C (2017) Delaying histone deacetylase response to injury accelerates conversion into repair Schwann cells and nerve regeneration. Nat Commun 8:14272. https://doi.org/10.1038/ncomms14272
Ma KH, Svaren J (2016) Epigenomic reprogramming in peripheral nerve injury. Neural Regener Res 11:1930–1931. https://doi.org/10.4103/1673-5374.197133
Ma KH, Svaren J (2018) Epigenetic control of Schwann cells. Neuroscientist 24:627–638. https://doi.org/10.1177/1073858417751112
Hung HA, Sun GN, Keles S, Svaren J (2015) Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. J Biol Chem 290:6937–6950. https://doi.org/10.1074/jbc.M114.622878
Brugger V, Engler S, Pereira JA, Ruff S, Horn M, Welzl H, Munger E, Vaquie A, Sidiropoulos PN, Egger B, Yotovski P, Filgueira L, Somandin C, Luhmann TC, D'Antonio M, Yamaguchi T, Matthias P, Suter U, Jacob C (2015) HDAC1/2-dependent P0 expression maintains paranodal and nodal integrity independently of myelin stability through interactions with neurofascins. PLoS Biol 13:e1002258. https://doi.org/10.1371/journal.pbio.1002258
Gordon T, Chan KM, Sulaiman OAR, Udina E, Amirjani N, Brushart TM (2009) Accelerating axon growth to overcome limitations in functional recovery after peripheral nerve injury. Neurosurgery 65:A132–A144. https://doi.org/10.1227/01.Neu.0000335650.09473.D3
He XL, Zhang LG, Queme LF, Liu XZ, Lu A, Waclaw RR, Dong XR, Zhou WH, Kidd G, Yoon SO, Buonanno A, Rubin JB, **n M, Nave KA, Trapp BD, Jankowski MP, Lu QR (2018) A histone deacetylase 3-dependent pathway delimits peripheral myelin growth and functional regeneration. Nat Med 24:338–351. https://doi.org/10.1038/nm.4483
Rosenberg LH, Cattin AL, Fontana X, Harford-Wright E, Burden JJ, White IJ, Smith JG, Napoli I, Quereda V, Policarpi C, Freeman J, Ketteler R, Riccio A, Lloyd AC (2018) HDAC3 regulates the transition to the homeostatic myelinating Schwann cell state. Cell Rep 25:2755–2765. https://doi.org/10.1016/j.celrep.2018.11.045
Gomez-Sanchez JA, Gomis-Coloma C, Morenilla-Palao C, Peiro G, Serra E, Serrano M, Cabedo H (2013) Epigenetic induction of the Ink4a/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge. Brain 136:2262–2278. https://doi.org/10.1093/brain/awt130
Wong KM, Babetto E, Beirowski B (2017) Axon degeneration: make the Schwann cell great again. Neural Regen Res 12:518–524. https://doi.org/10.4103/1673-5374.205000
Vargas ME, Barres BA (2007) Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 30:153–179. https://doi.org/10.1146/annurev.neuro.30.051606.094354
Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP (2005) The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (Wld(S)) nerves. BMC Neurosci 6:6. https://doi.org/10.1186/1471-2202-6-6
Brown MC, Lunn ER, Perry VH (1992) Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J Neurobiol 23:521–536. https://doi.org/10.1002/neu.480230507
Chen S, Bisby MA (1993) Impaired motor axon regeneration in the C57bl/Ola mouse. J Comp Neurol 333:449–454. https://doi.org/10.1002/cne.903330310
Huebner EA, Strittmatter SM (2009) Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ 48:339–351. https://doi.org/10.1007/400_2009_19
Lutz AB, Chung WS, Sloan SA, Carson GA, Zhou L, Lovelett E, Posada S, Zuchero JB, Barres BA (2017) Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Proc Natl Acad Sci USA 114:E8072–E8080. https://doi.org/10.1073/pnas.1710566114
Painter MW, Lutz AB, Cheng YC, Latremoliere A, Duong K, Miller CM, Posada S, Cobos EJ, Zhang AX, Wagers AJ, Havton LA, Barres B, Omura T, Woolf CJ (2014) Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration. Neuron 83:331–343. https://doi.org/10.1016/j.neuron.2014.06.016
Jha AK, Huang SCC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, Pearce EJ, Driggers EM, Artyomov MN (2015) Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42:419–430. https://doi.org/10.1016/j.immuni.2015.02.005
Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002) Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 22:6696–6703
Klein D, Martini R (2016) Myelin and macrophages in the PNS: An intimate relationship in trauma and disease. Brain Res 1641:130–138. https://doi.org/10.1016/j.brainres.2015.11.033
Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Mueller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, Radyushkin K, Goebbels S, Fischer TM, Franklin RJ, Lai C, Ehrenreich H, Birchmeier C, Schwab MH, Nave KA (2008) Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59:581–595. https://doi.org/10.1016/j.neuron.2008.06.028
Chen S, Velardez MO, Warot X, Yu ZX, Miller SJ, Cros D, Corfas G (2006) Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J Neurosci 26:3079–3086. https://doi.org/10.1523/Jneurosci.3785-05.2006
Freidin M, Asche S, Bargiello TA, Bennett MVL, Abrams CK (2009) Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1). Proc Natl Acad Sci USA 106:3567–3572. https://doi.org/10.1073/pnas.0813413106
Leimeroth R, Lobsiger C, Lussi A, Taylor V, Suter U, Sommer L (2002) Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent progenitor cells. Dev Biol 246:245–258. https://doi.org/10.1006/dbio.2002.0670
Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700–703. https://doi.org/10.1126/science.1095862
Morris JK, Lin WC, Hauser C, Marchuk Y, Getman D, Lee KF (1999) Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron 23:273–283. https://doi.org/10.1016/S0896-6273(00)80779-5
Newbern J, Birchmeier C (2010) Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin Cell Dev Biol 21:922–928. https://doi.org/10.1016/j.semcdb.2010.08.008
Syroid DE, Maycox PR, Burrola PG, Liu NL, Wen DZ, Lee KF, Lemke G, Kilpatrick TJ (1996) Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci USA 93:9229–9234. https://doi.org/10.1073/pnas.93.17.9229
Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu XR, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681–694. https://doi.org/10.1016/j.neuron.2005.08.017
Atanasoski S, Scherer SS, Sirkowski E, Leone D, Garratt AN, Birchmeier C, Suter U (2006) ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. J Neurosci 26:2124–2131. https://doi.org/10.1523/Jneurosci.4594-05.2006
Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA (1997) Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 17:1642–1659
Kwon YK, Bhattacharyya A, Alberta JA, Giannobile WV, Cheon KW, Stiles CD, Pomeroy SL (1997) Activation of ErbB2 during Wallerian degeneration of sciatic nerve. J Neurosci 17:8293–8299
Ronchi G, Haastert-Talini K, Fornasari BE, Perroteau I, Geuna S, Gambarotta G (2016) The Neuregulin1/ErbB system is selectively regulated during peripheral nerve degeneration and regeneration. Eur J Neurosci 43:351–364. https://doi.org/10.1111/ejn.12974
Bermingham-McDonogh O, Xu YT, Marchionni MA, Scherer SS (1997) Neuregulin expression in PNS neurons: isoforms and regulation by target interactions. Mol Cell Neurosci 10:184–195. https://doi.org/10.1006/mcne.1997.0654
Chen SZ, Rio C, Ji RR, Dikkes P, Coggeshall RE, Woolf CJ, Corfas G (2003) Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6:1186–1193. https://doi.org/10.1038/nn1139
Fricker FR, Antunes-Martins A, Galino J, Paramsothy R, La Russa F, Perkins J, Goldberg R, Brelstaff J, Zhu N, McMahon SB, Orengo C, Garratt AN, Birchmeier C, Bennett DLH (2013) Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination. Brain 136:2279–2297. https://doi.org/10.1093/brain/awt148
Hu XY, Hicks CW, He WX, Wong P, Macklin WB, Trapp BD, Yan RQ (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9:1520–1525. https://doi.org/10.1038/nn1797
Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C (2006) Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314:664–666. https://doi.org/10.1126/science.1132341
Farah MH, Pan BH, Hoffman PN, Ferraris D, Tsukamoto T, Nguyen T, Wong PC, Price DL, Slusher BS, Griffin JW (2011) Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J Neurosci 31:5744–5754. https://doi.org/10.1523/Jneurosci.6810-10.2011
Hu XY, He WX, Diaconu CD, Tang XY, Kidd GJ, Macklin WB, Trapp BD, Yan RQ (2008) Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J 22:2970–2980. https://doi.org/10.1096/fj.08-106666
Stassart RM, Fledrich R, Velanac V, Brinkmann BG, Schwab MH, Meijer D, Sereda MW, Nave KA (2013) A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci 16:48–54. https://doi.org/10.1038/nn.3281
Chen LE, Liu K, Seaber AV, Katragadda S, Kirk C, Urbaniak JR (1998) Recombinant human glial growth factor 2 (rhGGF2) improves functional recovery of crushed peripheral nerve (a double-blind study). Neurochem Int 33:341–351. https://doi.org/10.1016/s0197-0186(98)00037-0
Joung I, Yoo M, Woo JH, Chang CY, Heo H, Kwon YK (2010) Secretion of EGF-like domain of heregulin beta promotes axonal growth and functional recovery of injured sciatic nerve. Mol Cells 30:477–484. https://doi.org/10.1007/s10059-010-0137-5
Yildiz M, Karlidag T, Yalcin S, Ozogul C, Keles E, Alpay HC, Yanilmaz M (2011) Efficacy of glial growth factor and nerve growth factor on the recovery of traumatic facial paralysis. Eur Arch Otorhinolaryngol 268:1127–1133. https://doi.org/10.1007/s00405-011-1492-3
Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA (2005) Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci 25:3478–3487. https://doi.org/10.1523/Jneurosci.3766-04.2005
Fledrich R, Akkermann D, Schütza V, Abdelaal TA, Hermes D, Schäffner E, Soto-Bernardini MC, Götze T, Klink A, Kusch K, Krueger M, Kungl T, Frydrychowicz C, Möbius W, Brück W, Mueller WC, Bechmann I, Sereda MW, Schwab MH, Nave KA, Stassart RM (2019) NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nat Commun 10:146. https://doi.org/10.1038/s41467-019-09385-6
Yamauchi J, Miyamoto Y, Chan JR, Tanoue A (2008) ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration. J Cell Biol 181:351–365. https://doi.org/10.1083/jcb.200709033
Hansen JR, Roehm PC, Chatterjee P, Green SH (2006) Constitutive neuregulin–1/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53:593–600. https://doi.org/10.1002/glia.20316
Tapinos N, Ohnishi M, Rambukkana A (2006) ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med 12:961–966. https://doi.org/10.1038/nm0906-1100a
Zanazzi G, Einheber S, Westreich R, Hannocks MJ, Bedell-Hogan D, Marchionni MA, Salzer JL (2001) Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol 152:1289–1299. https://doi.org/10.1083/jcb.152.6.1289
Defelipe C, Hunt SP (1994) The differential control of c-Jun expression in regenerating sensory neurons and their associated glial-cells. J Neurosci 14:2911–2923
Parkinson DB, Bhaskaran A, Droggiti A, Dickinson S, D'Antonio M, Mirsky R, Jessen KR (2004) Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol 164:385–394. https://doi.org/10.1083/jcb.200307132
Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, Feltri ML, Wrabetz L, Behrens A, Mirsky R, Jessen KR (2008) c-Jun is a negative regulator of myelination. J Cell Biol 181:625–637. https://doi.org/10.1083/jcb.200803013
Klein D, Groh J, Wettmarshausen J, Martini R (2014) Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation. Glia 62:736–750. https://doi.org/10.1002/glia.22638
Hantke J, Carty L, Wagstaff LJ, Turmaine M, Wilton DK, Quintes S, Koltzenburg M, Baas F, Mirsky R, Jessen KR (2014) c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Brain 137:2922–2937. https://doi.org/10.1093/brain/awu257
Stratton JA, Shah PT (2016) Macrophage polarization in nerve injury: do Schwann cells play a role? Neural Regen Res 11:53–57. https://doi.org/10.4103/1673-5374.175042
Myers RR, Sekiguchi Y, Kikuchi S, Scott B, Medicherla S, Protter A, Campana WM (2003) Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 184:606–614. https://doi.org/10.1016/S0014-4886(03)00297-8
Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, Rosenberg LH, Collins MJ, Harrisingh MC, White IJ, Woodhoo A, Lloyd AC (2012) A central role for the erk-signaling pathway in controlling schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73:729–742. https://doi.org/10.1016/j.neuron.2011.11.031
Sheu JY, Kulhanek DJ, Eckenstein FP (2000) Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Exp Neurol 166:392–402. https://doi.org/10.1006/exnr.2000.7508
Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50–83. https://doi.org/10.1128/Mmbr.00031-10
Pearson G, Robinson F, Gibson TB, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153–183. https://doi.org/10.1210/er.22.2.153
Ishii A, Furusho M, Dupree JL, Bansal R (2014) Role of ERK1/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS. J Neurosci 34:16031–16045. https://doi.org/10.1523/Jneurosci.3360-14.2014
Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R (2012) ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci 32:8855–8864. https://doi.org/10.1523/Jneurosci.0137-12.2012
Newbern JM, Li XY, Shoemaker SE, Zhou JA, Zhong JA, Wu YH, Bonder D, Hollenback S, Coppola G, Geschwind DH, Landreth GE, Sniderl WD (2011) Specific functions for ERK/MAPK signaling during PNS development. Neuron 69:91–105. https://doi.org/10.1016/j.neuron.2010.12.003
Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, Lloyd AC (2004) The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J 23:3061–3071. https://doi.org/10.1038/sj.emboj.7600309
Syed N, Reddy K, Yang DP, Taveggia C, Salzer JL, Maurel P, Kim HA (2010) Soluble Neuregulin-1 Has Bifunctional, Concentration-dependent effects on Schwann cell myelination. J Neurosci 30:6122–6131. https://doi.org/10.1523/Jneurosci.1681-09.2010
Monje PV, Soto J, Bacallao K, Wood PM (2010) Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: role of cAMP and JNK in the maintenance of the differentiated state. J Biol Chem 285:31024–31036. https://doi.org/10.1074/jbc.M110.116970
Yang DP, Kim J, Syed N, Tung YJ, Bhaskaran A, Mindos T, Mirsky R, Jessen KR, Maurel P, Parkinson DB, Kim HA (2012) p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination. J Neurosci 32:7158–7168. https://doi.org/10.1523/Jneurosci.5812-11.2012
Cervellini I, Galino J, Zhu N, Allen S, Birchmeier C, Bennett DL (2018) Sustained MAPK/ERK activation in adult Schwann cells impairs nerve repair. J Neurosci 38:679–690. https://doi.org/10.1523/Jneurosci.2255-17.2017
Grossmann KS, Wende H, Paul FE, Cheret C, Garratt AN, Zurborg S, Feinberg K, Besser D, Schulz H, Peles E, Selbach M, Birchmeier W, Birchmeier C (2009) The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development. Proc Natl Acad Sci USA 106:16704–16709. https://doi.org/10.1073/pnas.0904336106
He Y, Kim JY, Dupree J, Tewari A, Melendez-Vasquez C, Svaren J, Casaccia P (2010) Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat Neurosci 13:1472–1480. https://doi.org/10.1038/nn.2686
Haines JD, Fragoso G, Hossain S, Mushynski WE, Almazan G (2008) p38 Mitogen-activated protein kinase regulates myelination. J Mol Neurosci 35:23–33. https://doi.org/10.1007/s12031-007-9011-0
Baron W, Metz B, Bansal R, Hoekstra D, de Vries H (2000) PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15:314–329. https://doi.org/10.1006/mcne.1999.0827
Bhat NR, Zhang PS, Mohanty SB (2007) p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target. Neurochem Res 32:293–302. https://doi.org/10.1007/s11064-006-9274-9
Chew LJ, Coley W, Cheng Y, Gallo V (2010) Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci 30:11011–11027. https://doi.org/10.1523/Jneurosci.2546-10.2010
Fragoso G, Haines JD, Roberston J, Pedraza L, Mushynski WE, Almazan G (2007) p38 Mitogen–activated protein kinase is required for central nervous system myelination. Glia 55:1531–1541. https://doi.org/10.1002/glia.20567
Kato N, Matsumoto M, Kogawa M, Atkins GJ, Findlay DM, Fujikawa T, Oda H, Ogata M (2013) Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. J Neuroinflam 10(1):1. https://doi.org/10.1186/1742-2094-10-1
Apra C, Richard L, Coulpier F, Blugeon C, Gilardi-Hebenstreit P, Vallat JM, Lindner V, Charnay P, Decker L (2012) Cthrc1 is a negative regulator of myelination in schwann cells. Glia 60:393–403. https://doi.org/10.1002/glia.22273
Yamauchi J, Chan JR, Shooter EM (2003) Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway. Proc Natl Acad Sci USA 100:14421–14426. https://doi.org/10.1073/pnas.2336152100
Yamauchi J, Miyamoto Y, Hamasaki H, Sanbe A, Kusakawa S, Nakamura A, Tsumura H, Maeda M, Nemoto N, Kawahara K, Torii T, Tanoue A (2011) The atypical guanine-nucleotide exchange factor, Dock7, negatively regulates Schwann cell differentiation and myelination. J Neurosci 31:12579–12592. https://doi.org/10.1523/Jneurosci.2738-11.2011
Jung JU, Cai W, Lee HK, Pellegatta M, Shin YK, Jang SY, Suh DJ, Wrabetz L, Feltri ML, Park HT (2011) Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration. J Neurosci 31:2009–2015. https://doi.org/10.1523/JNEUROSCI.4537-10.2011
Pattingre S, Bauvy C, Carpentier S, Levade T, Levine B, Codogno P (2009) Role of JNK1-dependent Bcl-2 phosphorylation in ceramide–induced macroautophagy. J Biol Chem 284:2719–2728. https://doi.org/10.1074/jbc.M805920200
Nguyen QT, Sanes JR, Lichtman JW (2002) Pre–existing pathways promote precise projection patterns. Nat Neurosci 5:861–867. https://doi.org/10.1038/nn905
Roberts SL, Dun XP, Doddrell RDS, Mindos T, Drake LK, Onaitis MW, Florio F, Quattrini A, Lloyd AC, D'Antonio M, Parkinson DB (2017) Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve. Development 144:3114–3125. https://doi.org/10.1242/dev.150656
Salzer JL (2008) Switching myelination on and off. J Cell Biol 181:575–577. https://doi.org/10.1083/jcb.200804136
Linneberg C, Harboe M, Laursen L (2015) Axo-glia interaction preceding CNS myelination is regulated by bidirectional Eph-ephrin signaling. ASN Neuro 7:1759091415602859. https://doi.org/10.1177/1759091415602859
Dun XP, Carr L, Woodley PK, Barry RW, Drake LK, Mindos T, Roberts SL, Lloyd AC, Parkinson DB (2019) Macrophage-derived Slit3 controls cell migration and axon pathfinding in the peripheral nerve bridge. Cell Rep 26:1458–1472. https://doi.org/10.1016/j.celrep.2018.12.081
Blockus H, Chedotal A (2016) Slit-Robo signaling. Development 143:3037–3044. https://doi.org/10.1242/dev.132829
Cattin AL, Burden JJ, Van Emmenis L, Mackenzie FE, Hoving JJ, Garcia Calavia N, Guo Y, McLaughlin M, Rosenberg LH, Quereda V, Jamecna D, Napoli I, Parrinello S, Enver T, Ruhrberg C, Lloyd AC (2015) Macrophage-induced blood vessels guide Schwann cell-mediated regeneration of peripheral nerves. Cell 162:1127–1139. https://doi.org/10.1016/j.cell.2015.07.021
Benito C, Davis CM, Gomez-Sanchez JA, Turmaine M, Meijer D, Poli V, Mirsky R, Jessen KR (2017) STAT3 controls the long-term survival and phenotype of repair Schwann cells during nerve regeneration. J Neurosci 37:4255–4269. https://doi.org/10.1523/JNEUROSCI.3481-16.2017
Zujovic V, Bachelin C, Baron-Van Evercooren A (2007) Remyelination of the central nervous system: a valuable contribution from the periphery. Neuroscientist 13:383–391. https://doi.org/10.1177/10738584070130041001
Woodhoo A, Alonso MB, Droggiti A, Turmaine M, D'Antonio M, Parkinson DB, Wilton DK, Al-Shawi R, Simons P, Shen J, Guillemot F, Radtke F, Meijer D, Feltri ML, Wrabetz L, Mirsky R, Jessen KR (2009) Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci 12:839–847. https://doi.org/10.1038/nn.2323
Mirsky R, Woodhoo A, Parkinson DB, Arthur-Farraj P, Bhaskaran A, Jessen KR (2008) Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation. J Peripher Nerv Syst 13:122–135. https://doi.org/10.1111/j.1529-8027.2008.00168.x
Wang J, Ren KY, Wang YH, Kou YH, Zhang PX, Peng JP, Deng L, Zhang HB, Jiang BG (2015) Effect of active Notch signaling system on the early repair of rat sciatic nerve injury. Artif Cells Nanomed Biotechnol 43:383–389. https://doi.org/10.3109/21691401.2014.896372
Zochodne DW (2012) The challenges and beauty of peripheral nerve regrowth. J Peripher Nerv Syst 17:1–18. https://doi.org/10.1111/j.1529-8027.2012.00378.x
Acknowledgements
Open Access funding provided by Projekt DEAL. Grant sponsors: International Foundation for Research in Paraplegia (IRP), Grant no. P 174.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nocera, G., Jacob, C. Mechanisms of Schwann cell plasticity involved in peripheral nerve repair after injury. Cell. Mol. Life Sci. 77, 3977–3989 (2020). https://doi.org/10.1007/s00018-020-03516-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-020-03516-9